Back to search

Netherlands· NL-b30d152d55b3

Gaviscon Duo Bosvruchten, kauwtabletten

A alginic acid product containing calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)), registered in Netherlands by Reckitt Benckiser Healthcare B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC A02BX13

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGaviscon Duo Bosvruchten, kauwtablett…ATCA02BX13REGISTER NO.NL-b30d152d55b3PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Alginic acid is registered in 10 of 19 countries.

Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Alginic acid · ATC A02BX13

10 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CALCIUMCARBONAAT (E 170) + NATRIUMALGINAAT (E 401) + NATRIUMWATERSTOFCARBONAAT (E 500 (II))
Manufacturer
Reckitt Benckiser Healthcare B.V.
Country
Netherlands (NL)
ATC code
A02BX13
ATC class
Alginic acid
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129550

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f556bbbc-281c-44a0-a00a-8e2f04187f63
GET /v1/drugs/f556bbbc-281c-44a0-a00a-8e2f04187f63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kauwtablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129550_smpc.pdf",
  "strength": null,
  "atc_label": "Alginic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129550",
  "excipients": [
    "ACESULFAAM KALIUM (E 950)",
    "ARABISCHE GOM (E 414)",
    "ARABISCHE GOM (E 414)",
    "ASPARTAAM (E 951)",
    "AZORUBINE ALUMINIUM LAK (E 122)",
    "CARMELLOSE NATRIUM (E 466)",
    "COPOVIDON (E 1208)",
    "FANTASIEFRUITSMAAKSTOF",
    "FRAMBOZENSMAAKSTOF",
    "GLYCEROLTRIACETAAT (E 1518)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "MACROGOL 20000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL, GEMODIFICEERD",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SACCHAROSE",
    "VEENBESSENSMAAKSTOF",
    "XYLITOL (E 967)"
  ],
  "substances": [
    "CALCIUMCARBONAAT (E 170)",
    "NATRIUMALGINAAT (E 401)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129550.pdf",
  "authorised_at": "2023/08/31",
  "procedure_number": "NL/H/5461/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "129550",
  "additional_monitoring": "N"
}

See everything about alginic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.